Log In
Print
BCIQ
Print
Print this Print this
 

MTL-501

  Manage Alerts
Collapse Summary General Information
Company MiNA Therapeutics Ltd.
DescriptionTriethanolamine-core poly(amidoamine) dendrimer-conjugated short activating RNA (saRNA) that activates the CEBPA gene
Molecular Target CCAAT enhancer binding protein alpha (CEBPA)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today